Search | IOVS | ARVO Journals

Showing 1 – 20 of 67

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Anatomy and Pathology/Oncology November 2024

Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research

PDF

Lauren A. Dalvin; Cynthia M. Andrews-Pfannkoch; David R. Miley; Tara L. Hogenson; Samantha A. Erickson; Shivani Malpotra; Kjersten J. Anderson; Mohammed E. Omer; Luciana L. Almada; Cheng Zhang; Hu Li; Diva R. Salomao; Carol L. Shields; Sara E. Lally; Rachel M. Malsch; James A. Armitage; Heather L. Holmes; Michael F. Romero; Michael P. Fautsch; Svetomir N. Markovic; Martin E. Fernandez-Zapico
TAGS: intraocular melanoma, neoplasms, organoids, translational research, immunohistochemistry, bap1 gene, transplantation, heterologous, atac trial
Invest. Ophthalmol. Vis. Sci.. 2024; 65(13):60. https://doi.org/10.1167/iovs.65.13.60

Includes: Supplemental Content

Clinical and Epidemiologic Research July 2023

Conditional Metastasis of Uveal Melanoma in 8091 Patients over Half-Century (51 Years) by Age Group: Assessing the Entire Population and the Extremes of Age

PDF

Carol L. Shields; Annika G. Samuelson; Glenn J. Oh; Joseph D. DeSimone; Zaynab L. Sajjadi; Zeynep Bas; Nicholas E. Kalafatis; Sara E. Lally; Jerry A. Shields; Philip W. Dockery
TAGS: intraocular melanoma, neoplasm metastasis
Invest. Ophthalmol. Vis. Sci.. 2023; 64(10):7. https://doi.org/10.1167/iovs.64.10.7

ARVO Annual Meeting Abstract June 2023

The Cancer Genome Atlas cytogenetic analysis of choroidal nevus with transformation to melanoma

Kevin R. Card; Alexandra R. Zaloga; Eleni Konstantinou; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):884.

ARVO Annual Meeting Abstract June 2023

A multicenter analysis of nucleic acid quantification using aqueous humor liquid biopsy in retinoblastoma – Implications for clinical testing

Liya Xu; Deborah Im; Sarah Pike; Mark Reid; Chen-Ching Peng; Hans E Grossniklaus; G. Baker Hubbard; Alison Skalet; Carol L. Shields; Sarah E. Lally; Andrew W Stacey; Bibiana J. Reiser; Aaron Nagiel; Rachana Shah; Jesse L Berry

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1258.

ARVO Annual Meeting Abstract June 2022

BAP1 immunohistochemistry in post-brachytherapy uveal melanoma

Maya Eiger-Moscovich; Carol L. Shields; Ralph C. Eagle Jr.; Tatyana Milman

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1456.

Articles February 2021

White Paper on Ophthalmic Imaging for Choroidal Nevus Identification and Transformation into Melanoma

PDF

Carol L. Shields; Sara E. Lally; Lauren A. Dalvin; Mandeep S. Sagoo; Marco Pellegrini; Swathi Kaliki; Ahmet Kaan Gündüz; Minoru Furuta; Prithvi Mruthyunjaya; Adrian T. Fung; Jay S. Duker; Sara M. Selig; Antonio Yaghy; Sandor R. Ferenczy; Malvina B. Eydelman; Mark S. Blumenkranz
TAGS: melanoma, nevus, nevus of choroid, ophthalmic imaging
Trans. Vis. Sci. Tech.. 2021; 10(2):24. https://doi.org/10.1167/tvst.10.2.24

ARVO Annual Meeting Abstract June 2020

Risk factors for tumor recurrence following primary intravenous chemotherapy (chemoreduction) for retinoblastoma in 869 eyes of 551 patients

Lauren A Dalvin; Zeynep Bas; Sameeksha Tadepalli; Raksha Rao; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2809.

ARVO Annual Meeting Abstract June 2020

Comparison of Primary Intra-arterial Chemotherapy for Retinoblastoma Based on Exophytic versus Endophytic Growth Pattern

Wan Thamolwan Surakiatchanukul; Stavropoula I. Tjoumakaris; Pascal M. Jabbour; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2810.

ARVO Annual Meeting Abstract June 2020

Conjunctival Melanoma: Features and Outcomes based on the Fitzpatrick Skin Type in 540 patients at a Single Ocular Oncology Center

Antonio Yaghy; Sarangdev Vaidya; Richard Pacheco; Lauren A Dalvin; Sara E. Lally; Jerry A. Shields; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4664.

ARVO Annual Meeting Abstract June 2020

Conjunctival Melanoma: Risk Factors for Recurrence or New Tumor in 540 Patients at a Single Ocular Oncology Center

Sarangdev Vaidya; Richard Pacheco; Antonio Yaghy; Lauren A Dalvin; Sara E. Lally; Jerry A. Shields; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4666.

ARVO Annual Meeting Abstract June 2020

Use of fundus image registration and flicker for tracking choroidal tumor changes

Susan Su; Niranchana Manivannan; Mary K Durbin; Sandor Ferenczy; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3640.

ARVO Annual Meeting Abstract June 2020

A Phase 1b/2 Open-label Clinical Trial to Evaluate the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma

Prithvi Mruthyunjaya; Amy C Schefler; Ivana K Kim; Christopher Bergstrom; Hakan Demirci; Tony Tsai; Abdhish R Bhavsar; Antonio Capone; Brian Marr; Tara A McCannel; Cameron Javid; Peter G Hovland; Michael I. Seider; Cadmus Rich; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4025.

ARVO Annual Meeting Abstract July 2019

Two year results of a phase 1b/2 open-label clinical trial of AU-011 for the treatment of small to medium choroidal melanoma

Tara A McCannel; Abdhish Bhavsar; Antonio Capone; Hakan Demirici; Ivana K Kim; Brian Marr; Cadmus Rich; Amy C Schefler; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):719.

ARVO Annual Meeting Abstract July 2019

Prophylactic Intravitreal Bevacizumab after Plaque Radiotherapy for Uveal Melanoma: Analysis of 1311 Eyes of 1310 Patients by Age

Michael Chang; Lauren A Dalvin; Li-Anne S Lim; Mehdi Mazloumi; Antonio Yaghy; Arman Mashayekhi; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):721.

ARVO Annual Meeting Abstract July 2019

Photoreceptor Morphology and Correlation with Subretinal Fluid Chronicity Associated with Choroidal Nevus

Antonio Yaghy; Lauren A Dalvin; Michael Yu; Mehdi Mazloumi; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):725.

ARVO Annual Meeting Abstract July 2019

Neonatal Retinoblastoma: Analysis of Treatment Outcomes in the Pre-Chemotherapy, Intravenous Chemotherapy, and Intra-arterial Chemotherapy Eras

David A Camp; Lauren A Dalvin; Rachel Schwendeman; Li-Anne S Lim; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2332.

ARVO Annual Meeting Abstract July 2019

Intravitreal melphalan for vitreoretinal lymphoma

Li-Anne S Lim; Lauren A Dalvin; David Ancona-Lezama; Michael Chang; Arman Mashayekhi; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2778.

ARVO Annual Meeting Abstract July 2019

Survival Times in Patients with Vitreoretinal Lymphoma. Analysis of 95 Patients at a Single Ocular Oncology Center.

Lauren A Dalvin; Li-Anne S Lim; David Ancona-Lezama; Mehdi Mazloumi; Michael Chang; Arman Mashayekhi; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3543.

ARVO Annual Meeting Abstract July 2019

Adenoma and adenocarcinoma of the retinal pigment epithelium: clinical and imaging characteristics, treatment options and histopathologic findings in 51 consecutive patients

Luis Acaba-Berrocal; Basil K Williams; Maura Di Nicola; J. Antonio Lucio-Alvarez; Jerry A Shields; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3550.

ARVO Annual Meeting Abstract July 2019

Factors predictive of retinal detachment resolution in Coats disease: Analysis of 187 eyes in 184 patients at a single center

Chloe TL Khoo; Sanika Udyaver; Lauren A Dalvin; Li-Anne S Lim; Hatice Tuba Atalay; Mehdi Mazloumi; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4054.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research

Conditional Metastasis of Uveal Melanoma in 8091 Patients over Half-Century (51 Years) by Age Group: Assessing the Entire Population and the Extremes of Age

The Cancer Genome Atlas cytogenetic analysis of choroidal nevus with transformation to melanoma

A multicenter analysis of nucleic acid quantification using aqueous humor liquid biopsy in retinoblastoma – Implications for clinical testing

BAP1 immunohistochemistry in post-brachytherapy uveal melanoma

White Paper on Ophthalmic Imaging for Choroidal Nevus Identification and Transformation into Melanoma

Risk factors for tumor recurrence following primary intravenous chemotherapy (chemoreduction) for retinoblastoma in 869 eyes of 551 patients

Comparison of Primary Intra-arterial Chemotherapy for Retinoblastoma Based on Exophytic versus Endophytic Growth Pattern

Conjunctival Melanoma: Features and Outcomes based on the Fitzpatrick Skin Type in 540 patients at a Single Ocular Oncology Center

Conjunctival Melanoma: Risk Factors for Recurrence or New Tumor in 540 Patients at a Single Ocular Oncology Center

Use of fundus image registration and flicker for tracking choroidal tumor changes

A Phase 1b/2 Open-label Clinical Trial to Evaluate the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma

Two year results of a phase 1b/2 open-label clinical trial of AU-011 for the treatment of small to medium choroidal melanoma

Prophylactic Intravitreal Bevacizumab after Plaque Radiotherapy for Uveal Melanoma: Analysis of 1311 Eyes of 1310 Patients by Age

Photoreceptor Morphology and Correlation with Subretinal Fluid Chronicity Associated with Choroidal Nevus

Neonatal Retinoblastoma: Analysis of Treatment Outcomes in the Pre-Chemotherapy, Intravenous Chemotherapy, and Intra-arterial Chemotherapy Eras

Intravitreal melphalan for vitreoretinal lymphoma

Survival Times in Patients with Vitreoretinal Lymphoma. Analysis of 95 Patients at a Single Ocular Oncology Center.

Adenoma and adenocarcinoma of the retinal pigment epithelium: clinical and imaging characteristics, treatment options and histopathologic findings in 51 consecutive patients

Factors predictive of retinal detachment resolution in Coats disease: Analysis of 187 eyes in 184 patients at a single center

To View More...

You must be signed into an individual account to use this feature.